LeMaitre Vascular (LMAT) Stock Forecast & Price Target
Score
LeMaitre Vascular, Inc. price target
| LMAT | |
|---|---|
| Low | $86.00 |
| Average | $97.00 |
| High | $110.00 |
| Upside vs current price | +22.3% |
The average target of $97.00 is +22.3% versus the current LMAT price of $79.29.
LeMaitre Vascular, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 2 |
| Buy | 2 |
| Hold | 4 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
8 analysts cover LMAT.
LeMaitre Vascular, Inc. EPS and revenue estimates
Published annual figures for LMAT on this page are 2026 EPS $2.84, 2027 EPS $3.17. Coverage under three analysts is omitted.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $2.84 | $276.27M |
| 2027 | $3.17 | $303.83M |
Is LeMaitre Vascular, Inc. a buy or sell?
Of the 8 analysts covering LeMaitre Vascular, Inc., 4 rate it a buy (2 strong buy and 2 buy), 4 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The LMAT consensus label is Buy, beside 4 buy-side ratings and 0 sell-side ratings.
The average target of $97.00 implies +22.3% versus the current price of $79.29.
The LMAT rating block is 8 published views with a Buy label. It does not tell you whether to buy or sell.
Reading the LeMaitre Vascular, Inc. forecast
the LeMaitre Vascular, Inc. is priced by the street between $86.00 and $110.00, average $97.00.
The gap from the $79.29 price to the LMAT average is +22.3%.
the LeMaitre Vascular, Inc. does not have a single rating camp: 4 of 8 analysts are on the buy side, 4 are at hold, and 0 are on the sell side, and the published consensus is Buy.
The LMAT average target is little changed, $98.00 over the last month and $98.00 over the last quarter.
With 8 analysts on LMAT, the average is a small sample.
LeMaitre Vascular, Inc. forecast questions
What is the LMAT price target?
The published range for LMAT is $86.00 to $110.00, with an average of $97.00. That average is +22.3% versus the current price of $79.29.
Is LeMaitre Vascular, Inc. a buy or sell?
Of the 8 analysts covering LeMaitre Vascular, Inc., 4 rate it a buy, 4 rate it a hold, and 0 rate it a sell. The consensus is Buy, leaving LMAT at 4 buy ratings, 4 holds, and 0 sells.
What is the EPS estimate for LeMaitre Vascular, Inc.?
Analyst EPS estimates for LeMaitre Vascular, Inc.: 2026 $2.84, 2027 $3.17.
What is the revenue estimate for LeMaitre Vascular, Inc.?
Analyst revenue estimates for LeMaitre Vascular, Inc.: 2026 $276.27M, 2027 $303.83M.
How many analysts cover LMAT?
8 analysts cover LMAT. Their consensus on LMAT is Buy, across those 8.